Ignite Creation Date:
2025-12-24 @ 2:55 PM
Ignite Modification Date:
2026-02-20 @ 6:46 PM
Study NCT ID:
NCT02059759
Status:
COMPLETED
Last Update Posted:
2025-11-17
First Post:
2014-02-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immuno-modulation in Amyotrophic Lateral Sclerosis- a Phase II Study of Safety and Activity of Low Dose Interleukin-2
Sponsor:
Centre Hospitalier Universitaire de Nīmes
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09
Start Date Type:
None
Primary Completion Date:
2016-05-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-05-25
Completion Date Type:
ACTUAL
First Submit Date:
2014-02-07
First Submit QC Date:
None
Study First Post Date:
2014-02-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-14
Last Update Post Date:
2025-11-17
Last Update Post Date Type:
ESTIMATED